Creegan & Nassoura Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $311K | Hold |
767
| – | – | 0.2% | 69 |
|
2025
Q1 | $382K | Hold |
767
| – | – | 0.25% | 68 |
|
2024
Q4 | $399K | Hold |
767
| – | – | 0.27% | 67 |
|
2024
Q3 | $474K | Hold |
767
| – | – | 0.3% | 66 |
|
2024
Q2 | $424K | Hold |
767
| – | – | 0.29% | 65 |
|
2024
Q1 | $446K | Hold |
767
| – | – | 0.3% | 65 |
|
2023
Q4 | $407K | Hold |
767
| – | – | 0.3% | 68 |
|
2023
Q3 | $388K | Hold |
767
| – | – | 0.3% | 67 |
|
2023
Q2 | $400K | Hold |
767
| – | – | 0.3% | 66 |
|
2023
Q1 | $442K | Hold |
767
| – | – | 0.34% | 67 |
|
2022
Q4 | $422K | Hold |
767
| – | – | 0.33% | 66 |
|
2022
Q3 | $389K | Hold |
767
| – | – | 0.34% | 70 |
|
2022
Q2 | $417K | Hold |
767
| – | – | 0.35% | 64 |
|
2022
Q1 | $453K | Hold |
767
| – | – | 0.34% | 66 |
|
2021
Q4 | $512K | Hold |
767
| – | – | 0.39% | 66 |
|
2021
Q3 | $438K | Sell |
767
-150
| -16% | -$85.7K | 0.37% | 65 |
|
2021
Q2 | $463K | Hold |
917
| – | – | 0.4% | 62 |
|
2021
Q1 | $419K | Hold |
917
| – | – | 0.37% | 61 |
|
2020
Q4 | $427K | Hold |
917
| – | – | 0.41% | 58 |
|
2020
Q3 | $405K | Hold |
917
| – | – | 0.44% | 57 |
|
2020
Q2 | $332K | Hold |
917
| – | – | 0.37% | 61 |
|
2020
Q1 | $260K | Hold |
917
| – | – | 0.34% | 62 |
|
2019
Q4 | $298K | Buy |
+917
| New | +$298K | 0.3% | 68 |
|